the Pharmacokinetic Profiles of Linagliptin With DW1029M

NCT02212782 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Linagliptin 5mg
DRUG: DW1029M 1200mg and Linagliptin 5mg

Sponsor

Dong Wha Pharmaceutical Co. Ltd.